Market Analysis Genome Editing Market 2019 New Business Study | Page 2

Global Genome Editing Market to 2025
www.theinsightpartners.com
According to a new market research study titled ‘Genome Editing Market to 2025 - Global Analysis and Forecasts by
Technology, Application and End User, the global genome editing market was valued at US$ 3,210.1 Mn in 2017 and is
estimated to reach US$ 10,691.0 Mn by 2025. The report highlights the trends prevalent in the global genome editing
market and the factors driving the market along with the restraints that are impacting its growth.
The technology segment is divided into transcription activator-like effector nucleases (TALENS), clustered regularly
interspaced short palindromic repeats (CRISPR), zinc finger nucleases (ZFNs), antisense RNA and others. Among the
technology segment the CRISPR holds the largest market share whereas, the TALENs is the fastest growing segment.
The dominancy is expected to be continued by the CRISPR owing to the advantages offered, elimination of invading
genetic material and enables the organisms to respond the changes. In addition, CRISPR-Cas9 is faster, cheaper and
more accurate than the other technologies of DNA editing and is used for the wide applications. It is considered to be
the simplest, most versatile and precise method of genetic manipulation. Moreover, the CRISPR technology is utilized in
every field of the genome editing. The market for genome editing by the technology segment is expected to reach US$
6,132.3 million by 2025 in the forecasted period. CRISPR segment has the highest market share in 2017, contributing
a market share of 53.6% and is expected to retain its dominance during the forecast period from 2018 to 2025 to
account for a market share of 57.4% of the overall revenue generated in 2025.
The report includes the driving factors such as increase in funding for the genome editing, rising prevalence of the
genetic disorders, rise in the advancements for the genome editing technology and rise in the production of the
genetically modified crops. The opportunities for the market is analyzed as the emerging markets for precision and
regenerative medicines. The usage of CRISOR Cas9 technology is the current for the genome editing market.
Key industry players operating in the field of genome editing across the globe include Transposagen
Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc., GenScript, Lonza, Horizon
Discovery Group plc, Sangamo Therapeutics, Inc., New England Biolabs, Editas Medicine, Merck KGaA.
The report segments the global genome editing market as follows:
Global Genome Editing Market – By Technology
TALENS
CRISPR
ZFN
Others
Global Genome Editing Market – By Application
Genetic Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Cell Line Engineering
2